MedPath

Effect of Computer-Assisted Cognitive Rehabilitation in Unilateral Spatial Neglect Patients with Brain Damage

Not Applicable
Completed
Conditions
Diseases of the nervous system
Registration Number
KCT0003420
Lead Sponsor
Hanyang University Seoul Hospital
Brief Summary

In this study, scores on the VST and VRT significantly improved in the CACR group, compared to the CR group, in brain damaged patients with hemiplegic neglect. The effect size for the variables in the CACR group indicated at least moderate improvement compared to the CR group. Thus, CACR may be a more useful intervention to improve attention and memory in brain damaged patients with hemiplegic neglect. Henceforth, classification of specific diseases and long-term follow-up studies on CACR depending on the functional status of patients are required.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
66
Inclusion Criteria

The inclusion criteria were as follows: patients who were diagnosed with brain damage or brain metabolic diseases by computerized tomography or magnetic resonance imaging; patients with suggested or indicated (moderate/severe) unilateral spatial neglect who under responding less than normal range of response behavior, classified by age and each response on the left or right side, as assessed by motor free visual perception test (MVPT); sufficient cognition to participate in the training as assessed by a Mini-Mental State Examination (MMSE), score of 18 or higher.

Exclusion Criteria

Those who met the participation criteria but did not agree to participate in the study.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Motor-Free Visual Perception Test (MVPT);Line Bisection Test (LBT)
Secondary Outcome Measures
NameTimeMethod
Visual Span Test –forward (VST);Visual Recognition Test (VRT);Korean version Modified Barthel Index (K-MBI);Mini-Mental State Examination Korean version (MMSE-K)
© Copyright 2025. All Rights Reserved by MedPath